GHW International (HKG:9933)

Market Cap	1.59B +21.9%
Revenue (ttm)	4.58B +6.5%
Net Income	14.15M -0.3%
EPS	0.01 -3.8%
Shares Out	945.22M
PE Ratio	116.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	1.680
Previous Close	1.680
Day's Range	1.680 - 1.680
52-Week Range	1.350 - 2.640
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About GHW International

GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People’s Republic of China, Europe, Vietnam, the rest of Asia, and internationally. It operates through seven segments: Methylamine Industry Series; Goldenhighway New Materials; Advanced Materials Intermediates Series; Green Products; Healthcare and Wellness; Iodine Derivatives and Supporting Products; and Happy Elephant Selections. The Methylamine Industry Series segment consists of animal nutrition chemical products, such as ch...

• Industry: Chemicals
• Sector: Materials
• Founded: 1995
• Employees: 1,109
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9933

Financial Performance

In 2025, GHW International's revenue was 4.11 billion, an increase of 6.51% compared to the previous year's 3.86 billion. Earnings were 12.72 million, a decrease of -0.28%.

Financial numbers in CNY